Ignite Creation Date:
2024-05-06 @ 5:42 PM
Last Modification Date:
2024-10-26 @ 2:34 PM
Study NCT ID:
NCT05406817
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2022-06-01
Brief Title:
Study of Radiolabeled Revumenib in Adults With Acute Leukemia
Sponsor:
Syndax Pharmaceuticals
Organization:
Syndax Pharmaceuticals
Organization Data
Organization:
Syndax Pharmaceuticals
Class:
INDUSTRY
Study ID:
SNDX-5613-0705
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Syndax Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None